期刊
CURRENT OPINION IN RHEUMATOLOGY
卷 33, 期 2, 页码 111-116出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/BOR.0000000000000783
关键词
coronavirus; COVID-19; observational study; outcomes research; registry
类别
资金
- American College of Rheumatology (ACR)
- European League Against Rheumatism (EULAR)
- National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC)
- NIH/NIAMS [P30AR070155]
The COVID-19 Global Rheumatology Alliance (GRA) has been successful in collecting and publishing a large volume of case data on patients with rheumatic disease with COVID-19. They have addressed challenges through a collaborative problem-solving approach and achieved their initial objectives. There remain numerous important areas for research which the GRA will continue to pursue as the pandemic evolves.
Purpose of review This review discusses the coronavirus disease-2019 (COVID-19) Global Rheumatology Alliance (GRA), the reason for its formation, the challenges with running the registry, and future opportunities for global collaborative research in rheumatology. Recent findings The GRA has been successful in collecting and publishing a large volume of case data on patients with rheumatic disease with COVID-19. In addition, the GRA has published reviews, opinion pieces, and patient-directed summaries of research to further assist in disseminating timely and accurate information about COVID-19 in rheumatic diseases. There have been numerous challenges in the journey but they have been addressed through a collaborative problem-solving approach. The initial objectives of the GRA to describe the outcomes in patients with rheumatic disease who developed COVID-19 have been achieved. There has been extensive use of the data in the clinic and also to try and understand the mechanisms of disease and opportunities for drug repurposing. There remain numerous important areas for research which the GRA will continue to pursue as the pandemic evolves.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据